A batch of arthritis medication is being recalled due to a labelling error. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on Wednesday that some packs had been distributed to pharmacies with incorrect labels.
The MHRA revealed that manufacturer Maxearn Limited had informed them that the label on an imported batch of Depo-Medrone had been 鈥渞eleased to the market with an error鈥. They stated that the vial label contained incorrect information regarding volume and total vial content.
The MHRA clarified: 鈥淭he label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total vial content is 80mg in 2 mL (with a concentration of 40mg/ml of methylprednisolone acetate). The error could result in the administration of the incorrect dose.
鈥淢axearn has contacted their distributor, 32 packs have been distributed to pharmacies. The remaining units provided to the distributor have been quarantined.
鈥淭he error only impacts the parallel imported product repackaged by Maxearn, packs from other sources are not affected and should continue to be dispensed.鈥